Literature DB >> 23008506

Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury.

Remo D Spescha1, Yi Shi, Susanne Wegener, Stephan Keller, Bruno Weber, Matthias M Wyss, Nadine Lauinger, Ghazaleh Tabatabai, Francesco Paneni, Francesco Cosentino, Christoph Hock, Michael Weller, Roger M Nitsch, Thomas F Lüscher, Giovanni G Camici.   

Abstract

AIMS: Stroke is a leading cause of morbidity and mortality, and its incidence increases with age. Both in animals and in humans, oxidative stress appears to play an important role in ischaemic stroke, with or without reperfusion. The adaptor protein p66(Shc) is a key regulator of reactive oxygen species (ROS) production and a mediator of ischaemia/reperfusion damage in ex vivo hearts. Hence, we hypothesized that p66(Shc) may be involved in ischaemia/reperfusion brain damage. To this end, we investigated whether genetic deletion of p66(Shc) protects from ischaemia/reperfusion brain injury. METHODS AND
RESULTS: Transient middle cerebral artery occlusion (MCAO) was performed to induce ischaemia/reperfusion brain injury in wild-type (Wt) and p66(Shc) knockout mice (p66(Shc-/-)), followed by 24 h of reperfusion. Cerebral blood flow and blood pressure measurements revealed comparable haemodynamics in both experimental groups. Neuronal nuclear antigen immunohistochemical staining showed a significantly reduced stroke size in p66(Shc-/-) when compared with Wt mice (P < 0.05, n = 7-8). In line with this, p66(Shc-/-) mice exhibited a less impaired neurological function and a decreased production of free radicals locally and systemically (P < 0.05, n = 4-5). Following MCAO, protein levels of gp91phox nicotinamide adenine dinucleotide phosphate oxidase subunit were increased in brain homogenates of Wt (P < 0.05, n = 4), but not of p66(Shc-/-) mice. Further, reperfusion injury in Wt mice induced p66(Shc) protein in the basilar and middle cerebral artery, but not in brain tissue, suggesting a predominant involvement of vascular p66(Shc).
CONCLUSION: In the present study, we show that the deletion of the ageing gene p66(Shc) protects mice from ischaemia/reperfusion brain injury through a blunted production of free radicals. The ROS mediator p66(Shc) may represent a novel therapeutical target for the treatment of ischaemic stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008506     DOI: 10.1093/eurheartj/ehs331

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

Review 1.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

2.  Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc.

Authors:  Fabian Bock; Khurrum Shahzad; Hongjie Wang; Stoyan Stoyanov; Juliane Wolter; Wei Dong; Pier Giuseppe Pelicci; Muhammed Kashif; Satish Ranjan; Simone Schmidt; Robert Ritzel; Vedat Schwenger; Klaus G Reymann; Charles T Esmon; Thati Madhusudhan; Peter P Nawroth; Berend Isermann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

Review 3.  Monoamine oxidases as sources of oxidants in the heart.

Authors:  Nina Kaludercic; Jeanne Mialet-Perez; Nazareno Paolocci; Angelo Parini; Fabio Di Lisa
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

Review 4.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

5.  Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc.

Authors:  Istvan Arany; Jeb Clark; Dustin K Reed; Luis A Juncos
Journal:  Nephrol Dial Transplant       Date:  2013-01-16       Impact factor: 5.992

Review 6.  P66Shc-SIRT1 Regulation of Oxidative Stress Protects Against Cardio-cerebral Vascular Disease.

Authors:  Xiangyi Kong; Jian Guan; Jun Li; Junji Wei; Renzhi Wang
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

7.  Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury.

Authors:  Alexander Akhmedov; Nicole R Bonetti; Martin F Reiner; Remo D Spescha; Heidi Amstalden; Mario Merlini; Daniel S Gaul; Candela Diaz-Cañestro; Sylvie Briand-Schumacher; Rebecca S Spescha; Aurora Semerano; Giacomo Giacalone; Gianluigi Savarese; Fabrizio Montecucco; Luka Kulic; Roger M Nitsch; Christian M Matter; Gerd A Kullak-Ublick; Maria Sessa; Thomas F Lüscher; Jürg H Beer; Luca Liberale; Giovanni G Camici
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-03       Impact factor: 6.200

8.  Remote ischemic conditioning enhances oxygen supply to ischemic brain tissue in a mouse model of stroke: Role of elevated 2,3-biphosphoglycerate in erythrocytes.

Authors:  Lin Wang; Changhong Ren; Yang Li; Chen Gao; Ning Li; Haiyan Li; Di Wu; Xiaoduo He; Changqing Xia; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-15       Impact factor: 6.200

9.  Aging-related alterations in eNOS and nNOS responsiveness and smooth muscle reactivity of murine basilar arteries are modulated by apocynin and phosphorylation of myosin phosphatase targeting subunit-1.

Authors:  Lubomir T Lubomirov; Symeon Papadopoulos; Sandra Pütz; Johannes Welter; Tim Klöckener; Kathrin Weckmüller; Mostafa A Ardestani; Dilyana Filipova; Doris Metzler; Harald Metzner; Jürgen Staszewski; Stefan Zittrich; Hristo Gagov; Mechthild M Schroeter; Gabriele Pfitzer
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 10.  Sleep, brain vascular health and ageing.

Authors:  Arehally M Mahalakshmi; Bipul Ray; Sunanda Tuladhar; Abid Bhat; Muhammed Bishir; Srinivasa Rao Bolla; Jian Yang; Musthafa Mohamed Essa; Saravana Babu Chidambaram; Gilles J Guillemin; Meena Kishore Sakharkar
Journal:  Geroscience       Date:  2020-08-03       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.